Zeitschrift für Gerontologie und Geriatrie

, Volume 40, Issue 4, pp 282–284 | Cite as

Stellungnahme zum IQWiG-Vorbericht A05-19B „Ginkgohaltige Präparate bei Alzheimer Demenz“

  • Manfred GogolEmail author
  • Dieter Lüttje
  • Cornel Sieber
  • Hansjörg Werner


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    IQWiG. Ginkgohaltige Präparate bei Alzheimer Demenz. Vorbericht A05- 19B. Köln: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); Dezember 2006. http:// V1%200.pdf (Zugriff 16. 01. 2007)Google Scholar
  2. 2.
    IQWiG. Methoden. Version 2.0 vom 19. 12. 2006. Köln: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); Dezember 2006. 2006_12_19_IQWiG_Methoden_V-2- 0.pdf (Zugriff 16. 01. 2007)Google Scholar
  3. 3.
    Birks J, Grimley Evans J (2006) Ginkgo biloba for cognitive impairment and dementia. The Cochrane Database of Systematic Reviews. Issue 3. CD003120Google Scholar
  4. 4.
    Kanowski S, Hoerr R (2003) Ginkgo biloba extract EGb 761® in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebocontrolled, randomized trial. Pharmacopsychiatry 36:297–303PubMedCrossRefGoogle Scholar
  5. 5.
    Le Bars PL, Katz MM, Berman N et al (1997) A placebo-controlled, double- blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278:1327–1332PubMedCrossRefGoogle Scholar
  6. 6.
    Le Bars PL, Velasco FM, Ferguson JM et al (2002) Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761® in Alzheimer’s disease. Neuropsychobiology 45:19–26PubMedCrossRefGoogle Scholar
  7. 7.
    Schneider LS, DeKosky ST, Farlow MR et al (2005) A randomized, double- blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer’s type. Curr Alzheimer Res 2:541–551PubMedCrossRefGoogle Scholar
  8. 8.
    Mazza M, Capuano A, Bria P et al (2006) Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo-controlled double-blind study. Eur J Neurol 13:981–985PubMedCrossRefGoogle Scholar
  9. 9.
    Langa KM, Foster NL, Larson EB (2004) Mixed dementia. Emerging concepts and therapeutic implications. JAMA 292:2901–2908PubMedCrossRefGoogle Scholar
  10. 10.
    Boustani M, Peterson B, Hanson L et al (2003) Screening for dementia in primary care: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 138:927–937PubMedGoogle Scholar
  11. 11.
    Mayeux R, Sano M (1999) Treatment of Alzheimer’s disease. N Engl J Med 341:1670–1679PubMedCrossRefGoogle Scholar
  12. 12.
    De Smet PAGM (2002) Herbal remedies. N Engl J Med 347:2046–2056PubMedCrossRefGoogle Scholar
  13. 13.
    Kawas CH (2003) Early Alzheimer’s disease. N Engl J Med 349:1056–1063PubMedCrossRefGoogle Scholar
  14. 14.
    Ahlemeyer B, Krieglstein J (2003) Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer’s disease. Pharmacopsychiatry 36(Suppl 3):S8–14PubMedCrossRefGoogle Scholar
  15. 15.
    Le Bars PL (2003) Response patterns of EGb 761® in Alzheimer’s disease: influence of neuropsychological profiles. Pharmacopsychiatry 36(Suppl 3):S50–55PubMedCrossRefGoogle Scholar
  16. 16.
    Hoerr R (2003) Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761®. Pharmacopsychiatry 36(Suppl 3):S56–61PubMedCrossRefGoogle Scholar
  17. 17.
    Le Bars PL (2003) Magnitude of effect and special approach to Ginkgo biloba extract EGb 761® in cognitive disorders. Pharmacopsychiatry 36 (Suppl 3):S44–49PubMedCrossRefGoogle Scholar
  18. 18.
    Van Dongen MCJM, van Rossum E, Kessels AGH et al (2000) The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairments: new results of a randomized clinical trial. J Am Geriatr Soc 48:1183–1194PubMedGoogle Scholar
  19. 19.
    Elsabagh S, Hartley DE, File SE (2005) Limited cognitive benefits in stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. J Psychopharm 19:173–181CrossRefGoogle Scholar
  20. 20.
    Geldmacher DS (2003) Alzheimer’s disease: current pharmacotherapy in the context of patient and family needs. J Am Geriatr Soc 51(5s2): S289–295PubMedCrossRefGoogle Scholar
  21. 21.
    Gauthier S (1999) Do we have a treatment for Alzheimer’s disease. Yes. Arch Neurol 56:738–739PubMedCrossRefGoogle Scholar
  22. 22.
    Pryse-Phillips W (1999) Do we have drugs for dementia? No. Arch Neurol 56:735–737PubMedCrossRefGoogle Scholar
  23. 23.
    Maidment I (2001) The use of ginkgo biloba in the treatment of dementia. Psychiatric Bulletin 25:353–356CrossRefGoogle Scholar
  24. 24.
    Ohen BS, Storzbach DM, Kaye JA (1998) The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55:1409–1415CrossRefGoogle Scholar
  25. 25.
    Salomon PR, Adams F, Silver A et al (2002) Ginkgo for memory enhancement. A randomized controlled trial. JAMA 2888:835–840CrossRefGoogle Scholar
  26. 26.
    Costa LG, Steardo L, Cuomo V (2004) Structural effects and neurofunctional sequelae of development exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev 56:103–147PubMedCrossRefGoogle Scholar
  27. 27.
    Chiapelli F, Navarro AM, Moradi DR et al (2006) Evidence-based research in complementary and alternative medicine III: Treatment of patients with Alzheimer’s disease. Evid Based Complement Alternat Med 3:411–424CrossRefGoogle Scholar
  28. 28.
    Fisher, Morley (2002) Antiaging medicine: the good, the bad, and the ugly. J Gerontol A Biol Sci Med Sci 57:M636–639PubMedGoogle Scholar
  29. 29.
    DeKosky ST (2003) Pathology and pathways of Alzheimer’s disease with an update on new developments in treatment. J Am Geriatr Soc 51:S314–320PubMedCrossRefGoogle Scholar
  30. 30.
    Geldmacher DS (2003) Alzheimer’s disease: current pharmacotherapy in the context of patient and family needs. J Am Geriatr Soc 51:S289–295PubMedCrossRefGoogle Scholar
  31. 31.
    McDougall GJ, Austin-Wells V, Zimmermann T (2005) Utility of neutraceutical products marketed for cognitive and memory enhancement. J Hol Nursing 23:415–433CrossRefGoogle Scholar
  32. 32.
    Andrieu S, Gillette S, Amouyal K et al (2003) Association of Alzheimer’s disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 and older from the EPIDOS study. J Gerontol A Biol Sci Med Sci 58:M372–377Google Scholar
  33. 33.
    Van Dongen M, van Rossum E, Kessels A et al (2003) Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol 56:367–376PubMedCrossRefGoogle Scholar
  34. 34.
    Wong AHC, Smith M, Boon HS (1998) Herbal remedies in psychiatric practise. Arch Gen Psychiatry 55:1033–1044PubMedCrossRefGoogle Scholar
  35. 35.
    Gogol M, Lüttje D, Werner H (2007) Stellungnahme zum Vorbericht des IQWiG „Cholinesterasehemmer bei Alzheimer Demenz“. Z Gerontol Geriat (im Druck)Google Scholar
  36. 36.
    Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with dementia. A national clinical guideline. Nr. 85, February 2006. (Zugriff 16. 01. 2007)Google Scholar
  37. 37.
    Doody RS, Stevens JC, Beck C et al (2001) Practise parameter: management of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1154–1166PubMedGoogle Scholar
  38. 38.
    Burns A, O‘Brien (2006) Clinical practice with anti-dementiva drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharm 20:732–755CrossRefGoogle Scholar
  39. 39.
    Warner J: DIGGER trial (Dementia in general practice: Ginkgo extract research trial). http://www.controlledtrials. com/ISRCTN 45577048Google Scholar
  40. 40.
    NIH awards multicenter study on Ginkgo biloba for dementia. http:// nccam-30.htm (Zugriff 16. 01. 2007)Google Scholar
  41. 41.
    Nahin RL, Fitzpatrick AL, Williamson JD et al (2006) Use of herbal medicine and other dietary supplements in community-dwelling older people: Baseline data from the Ginkgo Evaluation of Memory Study. J Am Geriatr Soc 54:1725–1735PubMedCrossRefGoogle Scholar
  42. 42.
    Vellas B, Andrieu S, Ousset PJ et al (2006) The Guid Age study. Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761® for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology 67 (Suppl 3):S6–11PubMedGoogle Scholar
  43. 43.
    Bundessozialgericht B 1 KR 7/05R vom 4. 4. 2006. http://juris. bundessozialgericht. de/cgi-bin/neu_entw_bsg/ &sid=38917c0152f11cf2c0e478dc 27440985&nr=9550&pos=0&anz=1 (Zugriff 19. 01. 2006)Google Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • Manfred Gogol
    • 1
  • Dieter Lüttje
    • 2
  • Cornel Sieber
    • 3
  • Hansjörg Werner
    • 4
  1. 1.Klinik für GeriatrieKrankenhaus LindenbrunnCoppenbrüggeGermany
  2. 2.Klinik für GeriatrieKlinikum OsnabrückOsnabrückGermany
  3. 3.Klinikum NordLehrstuhl Innere Medizin V (Geriatrie)NürnbergGermany
  4. 4.Klinik für GeriatrieEvangelisches Krankenhaus ElisabethenstiftDarmstadtGermany

Personalised recommendations